Sun Pharma Advanced Research Co Intrinsic Value
SPARC Valuation Methods Summary
| Method | Type | Intrinsic Value | Range | Upside/Downside | Details |
|---|---|---|---|---|---|
| Revenue Multiple Method | revenue | ₹39.71 | ₹35.74 - ₹43.68 | -70.0% | Revenue/Share: ₹9.70, P/S: 2.0x |
Want to compare with current market value? Check SPARC share price latest .
Valuation Comparison Chart
SPARC Intrinsic Value Analysis
What is the intrinsic value of SPARC?
Based on our comprehensive analysis using 1 different valuation methods, the estimated intrinsic value of Sun Pharma Advanced Research Co (SPARC) is ₹39.71 (median value). With the current market price of ₹132.38, this represents a -70.0% variance from our estimated fair value.
The valuation range spans from ₹39.71 to ₹39.71, indicating ₹39.71 - ₹39.71.
Is SPARC undervalued or overvalued?
Based on our multi-method analysis, Sun Pharma Advanced Research Co (SPARC) appears to be trading above calculated value by approximately 70.0%.
Financial Health Analysis
| Financial Metric | Current Value | Industry Benchmark | Assessment | Impact on Valuation |
|---|---|---|---|---|
| Current Ratio | 0.15 | Industry Standard: 2.0+ | Below 1.5 | Measures short-term liquidity capacity |
| Debt to Equity Ratio | -1.55 | Industry Standard: <0.5 | Below 0.5 | Indicates financial leverage level |
| Return on Equity | 140.1% | Industry Standard: 15%+ | Above 15% | Measures shareholder return efficiency |
| Operating Margin | -836.0% | Industry Standard: 20%+ | Below 10% | Indicates operational efficiency level |
| Asset Turnover Ratio | 0.10x | Industry Standard: 1.0x+ | Below 0.5x | Measures asset utilization efficiency |
Related Pages for Sun Pharma Advanced Research Co
Additional stock information and data for SPARC
Cash Flow Quality Analysis
| Period | Operating Cash Flow | Free Cash Flow | Cash Flow Quality | Sustainability Score |
|---|---|---|---|---|
| March 2025 | ₹-360 Cr | ₹-360 Cr | Negative Cash Flow | 3/10 |
| March 2024 | ₹-429 Cr | ₹-429 Cr | Negative Cash Flow | 3/10 |
| March 2023 | ₹-69 Cr | ₹-343 Cr | Negative Cash Flow | 3/10 |